Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.37 | -$0.37 | -$0.37 |
Q2 2024 | 1 | -$0.37 | -$0.37 | -$0.37 |
Q3 2024 | 1 | -$0.41 | -$0.41 | -$0.41 |
Q4 2024 | 1 | -$0.40 | -$0.40 | -$0.40 |
Q1 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
Q2 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
Q3 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
Q4 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
Acutus Medical, Inc. last posted its earnings results on Thursday, March 14th, 2024. The company reported $N/A earnings per share for the quarter, topping analysts' consensus estimates of $-0.3937 by $0.3937. The company had revenue of 5.27 M for the quarter and had revenue of 7.16 M for the year. Acutus Medical, Inc. has generated $-3 earnings per share over the last year ($-2.81 diluted earnings per share) and currently has a price-to-earnings ratio of -0.03. Acutus Medical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 8th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/14/2024 | Q3 2024 | -$0.19 | $7.76 M | $5.27 M | ||
08/08/2024 | Q2 2024 | -$0.03 | $7.59 M | $4.13 M | ||
05/09/2024 | Q1 2024 | -$0.05 | $3.63 M | |||
04/01/2024 | Q4 2023 | $0.26 | $-7,532,000 | |||
11/08/2023 | Q3 2023 | -$0.57 | -$0.45 | 0.12 | $4.81 M | $5.24 M |
08/07/2023 | Q2 2023 | -$0.61 | -$0.63 | -0.02 | $4.49 M | $5.29 M |
05/11/2023 | Q1 2023 | -$0.66 | -$0.58 | 0.08 | $4.17 M | |
03/23/2023 | Q4 2022 | $0.53 | $4.96 M | |||
11/10/2022 | Q3 2022 | -$0.83 | -$0.72 | 0.11 | $3.67 M | $3.64 M |
08/11/2022 | Q2 2022 | -$0.83 | -$0.12 | 0.71 | $3.84 M | $4.08 M |
05/12/2022 | Q1 2022 | -$0.99 | -$1.48 | -0.49 | $3.68 M | |
03/30/2022 | Q4 2021 | -$0.92 | -$1.12 | -0.2 | $4.36 M | |
11/12/2021 | Q3 2021 | -$0.94 | $5.38 M | $4.60 M | ||
08/12/2021 | Q2 2021 | -$1.02 | $4.36 M | $4.71 M | ||
05/12/2021 | Q1 2021 | -$1.04 | $3.59 M | |||
03/18/2021 | Q4 2020 | -$1.05 | $2.57 M | |||
11/12/2020 | Q3 2020 | -$1.95 | $3.03 M | $3.17 M | ||
09/18/2020 | Q2 2020 | -$0.94 | $1.09 M | $1.13 M | ||
03/30/2020 | Q1 2020 | -$1.05 | $1.58 M | |||
12/30/2019 | Q4 2019 | -$1.15 | $669,000 |
Acutus Medical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 8th, 2024 based off last year's report dates.
The conference call for Acutus Medical, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Acutus Medical, Inc.'s latest earnings report can be read online.
Acutus Medical, Inc. (:AFIB) has a recorded annual revenue of $7.16 M.
Acutus Medical, Inc. (:AFIB) has a recorded net income of $7.16 M. Acutus Medical, Inc. has generated $-2.81 earnings per share over the last four quarters.
Acutus Medical, Inc. (:AFIB) has a price-to-earnings ratio of -0.03 and price/earnings-to-growth ratio is -0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED